Skip to content

Eastman Chemical

US · EMN #1730 by market cap Listed 1970
58.77 -2.94 -4.76%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 12 in the most recent period (2026/Q3).
  • Total institutional ownership rose 6.1 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
101.19% +6.10pp
Institutions
761 +12
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund82.21%
Hedge Fund6.56%
Public Company5.36%
Government Pension Fund2.65%
Private Company2.43%
Sovereign Wealth Fund1.17%
Individual/Insider0.80%
Family Office/Trust0.35%
Insurance Company0.32%
Other5.18%

Top holders as of 2026-09-30

BlackRock 15.95% · 18.23M sh
Vanguard Portfolio Management, LLC 6.23% · 7.12M sh
Dimensional Fund Advisors 4.75% · 5.44M sh
Vanguard Capital Management, LLC 4.49% · 5.14M sh
State Street Global Advisors 3.70% · 4.23M sh
Morgan Stanley 2.60% · 2.97M sh
Morgan Stanley Investment Management Inc. 2.60% · 2.97M sh
Putnam LLC 2.49% · 2.85M sh
EARNEST Partners, LLC 2.10% · 2.40M sh
Capital Research 1.92% · 2.19M sh
Boston Partners Global Investors, Inc. 2.45% · 2.80M sh
MFS Investment Management 2.33% · 2.66M sh
Allspring Global Investments, LLC 1.91% · 2.18M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 45 buys · 5 sells

NameRoleStake
Mark Costa Chairperson & CEO 0.44%
Brad Lich Executive Vice President 0.09%
Stephen Crawford EVP, CTO & Chief Sustainability Officer 0.06%
William McLain Chief Financial Officer 0.06%
Renee Hornbaker Independent Director 0.02%
B. Smith Executive VP of Additives & Functional Products, Manufacturing, WWE&C and HSE 0.02%
Christopher Killian Former Senior VP, Chief Technology & Sustainability Officer 0.02%
Julie McAlindon Senior VP of Regions & Chief Supply Chain Officer 0.02%
Julie Holder Independent Director 0.02%
Eric Butler Independent Director 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-05 Julie McAlindon Senior VP of Regions & Chief Supply Chain Officer Open Market Acquisition +2,451 $65.28
2026-10-06 Donald Slager Independent Director Other Derivative Acquisition +480 --
2026-10-06 James O’Brien Independent Director Other Derivative Acquisition +480 --
2026-10-06 Renee Hornbaker Independent Director Other Derivative Acquisition +480 --
2026-10-06 Brett Begemann Lead Independent DIrector Other Derivative Acquisition +1,842 --
2026-10-06 Damon Audia Independent Director Other Derivative Acquisition +1,482 --
2026-10-06 Julie Holder Independent Director Other Derivative Acquisition +480 --
2026-10-06 Humberto Alfonso Independent Director Other Derivative Acquisition +1,642 --
2026-10-06 Eric Butler Independent Director Other Derivative Acquisition +480 --
2026-10-06 Kim Mink Independent Director Other Derivative Acquisition +480 --
2026-10-06 Linnie Haynesworth Independent Director Other Derivative Acquisition +480 --
2026-09-01 James O’Brien Independent Director Other Acquisition +7,860 --
2026-09-01 James O’Brien Independent Director Other Disposition -7,860 --
2026-08-03 Adrian Holt Chief Human Resources Officer Open Market Disposition -3,283 $71.31
2026-05-31 Adrian Holt Chief Human Resources Officer Derivative Exercise and Sale -1,058 $75.49
2026-05-31 Adrian Holt Chief Human Resources Officer Derivative Exercise and Retained +3,283 --
2026-05-06 Donald Slager Independent Director Other Acquisition +1,628 --
2026-05-06 James O’Brien Independent Director Other Acquisition +1,628 --
2026-05-06 Renee Hornbaker Independent Director Other Acquisition +1,628 --
2026-05-06 Brett Begemann Lead Independent DIrector Other Derivative Acquisition +1,628 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Eastman Chemical discussion 0 comments

Add a comment